ArticleOncoTargets and therapy2018

Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling [Retraction].

No numbers read from the abstract.

Not cited yet